Skip to content

Study · Animal study (in vivo) · rat · 1994

1 result

Suppression of retroviral tumors in hosts immune to viral oncogene product.

Maruyama K, Miyauchi M, Mochizuki S, Fukushima T, Koshikawa N, Kawamura K, Awaya A, Kobayashi H

Leukemia1 Apr 1994

PMID8152290 (opens in a new tab)PepBankPUB-08152290

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats studied for retrovirus-induced tumors, FTS showed suppressive effects on tumor development.

    In plain wordsIn rats studied for retrovirus-induced tumors, FTS suppressed tumor development.

    Outcome
    DecreaseTumor development
    Study

    ratn: not reported in source

    ST-FeSV-induced tumors in Wistar/Ma rats
    Outcome group
    Tumor growth · Cancer
    Studied dose
    Dose not stated

    Source sentences

    Summary
    A nonapeptide known to be thymic hormone (FTS) showed suppressive effects on tumor development.
    1 context sentence
    Summary · context
    Feline sarcoma virus of Snyder-Theilen strain (ST-FeSV) induces sarcomas in Wistar/Ma rats following neonatal virus injection.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.